MARKET

OABI

OABI

OmniAb, Inc.
NASDAQ
1.560
+0.050
+3.31%
After Hours: 1.560 0 0.00% 16:10 03/30 EDT
OPEN
1.530
PREV CLOSE
1.510
HIGH
1.570
LOW
1.505
VOLUME
199.20K
TURNOVER
--
52 WEEK HIGH
2.425
52 WEEK LOW
1.220
MARKET CAP
225.86M
P/E (TTM)
-2.7364
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and OmniAb (OABI)
TipRanks · 16h ago
Weekly Report: what happened at OABI last week (0323-0327)?
Weekly Report · 19h ago
Weekly Report: what happened at OABI last week (0316-0320)?
Weekly Report · 03/23 09:06
Weekly Report: what happened at OABI last week (0309-0313)?
Weekly Report · 03/16 09:06
OmniAb Earnings Call Highlights Platform Growth, Cash Path
TipRanks · 03/10 00:25
OmniAb publishes corporate overview highlighting 107 active partners and over USD 3 billion in potential milestones
Reuters · 03/09 12:10
Weekly Report: what happened at OABI last week (0302-0306)?
Weekly Report · 03/09 09:06
Analysts Offer Insights on Healthcare Companies: OmniAb (OABI) and Cresco Labs (OtherCRLBF)
TipRanks · 03/09 07:40
More
About OABI
OmniAb, Inc. licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to identify optimal antibodies and other target-binding proteins for its partners’ drug development efforts. Central to the OmniAb platform, Biological Intelligence, powers the immune systems of its engineered transgenic animals to create optimized antibody candidates for human therapeutics. Its proprietary transgenic animals, including OmniRat, OmniChicken and OmniMouse are genetically modified to generate antibodies with human sequences to streamline the development of human therapeutic candidates. OmniFlic and OmniClic are fixed or common light-chain rats and chickens, designed to facilitate the discovery of bispecific antibodies. OmniTaur provides cow-inspired antibodies with unique structural characteristics for challenging targets.

Webull offers OmniAB Inc stock information, including NASDAQ: OABI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OABI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OABI stock methods without spending real money on the virtual paper trading platform.